RCS - BioGX - BioGX Candida Auris PCR Assay Global Adoption

Thermo Fisher ScientificAnnouncement

24/07/2023 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230724:nRSX8784Ga&default-theme=true

RNS Number : 8784G  BioGX  24 July 2023

BioGX Candida Auris PCR Assay Global Adoption Accelerates

BIRMINGHAM, AL / ACCESSWIRE / July 24, 2023 / BioGX, a global provider of easy
molecular diagnostic solutions, announced accelerated adoption of their high
performance Sample-Ready™ PCR assay* for detection of Candida auris, a
rapidly spreading, hard to treat fungus with a growing presence in hospitals
and long-term care facilities. A complete PCR mix is provided in a single
lyophilized tube format to be validated by laboratories on a variety of
real-time PCR instruments including the BD MAX, ThermoFisher QuantStudio,
BioRAD CFX Touch and the new BioGX pixl™ platform.

"Our platform agnostic Candida auris PCR assay has been successfully validated
and implemented by numerous public health laboratories and hospitals," said
Shahin Iqbal, PhD, BioGX President & COO." He further added, "We are
grateful that laboratories trust us to address their unmet needs for detection
of emerging pathogens."

Dr. Margie Morgan, Director, Clinical Microbiology Pathology and Laboratory
Medicine at Cedars Sinai Hospital in California said "the BioGX Candida auris
PCR assay provides a rapid and sensitive method to perform surveillance
testing for our patient population. The real time results have been used by
our Epidemiology team to institute timely isolation precautions to
successfully prevent C. auris transmission in our medical center."

BioGX's Sample-Ready™ line of products offer custom manufactured or Research
Use Only PCR assays, lyophilized in a single vial and fine-tuned to ensure
high performance across multiple platforms that are commonly used in
laboratories today.

Additional information can be requested by contacting BioGX at info@biogx.com
(https://pr.report/mcxj29bN) .

*Research Use Only, Not intended for human or animal diagnostic use.

Sample-Ready, Just Add Water, Xfree and pixl are trademarks of BioGX, Inc.

Contact Information

Bill Standwill

Head of Marketing
marketing@biogx.com (mailto:marketing@biogx.com)

(205) 250-8055

SOURCE: BioGX

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUOSKRORUBUAR